<DOC>
	<DOCNO>NCT02738827</DOCNO>
	<brief_summary>Laser treatment pTa low grade bladder tumour outpatient department Number Subjects/Centres Planned : 20 patient include study . The study perform Department Urology , Bispebjerg-Frederiksberg Hospital , Copenhagen , Denmark . Primary Objective : To show small pTa bladder tumour safely remove diode laser outpatient department Secondary Objective : To evaluate patient experience laser treatment use QOL questionaires ( symptom evaluation ) Visual Analog Scale Score ( pain evaluation ) .</brief_summary>
	<brief_title>Diode Laser Treatment Bladder Tumors</brief_title>
	<detailed_description>Laser treatment pTa low grade bladder tumour outpatient department Number Subjects/Centres Planned : 20 patient include study . The study perform Department Urology , Bispebjerg-Frederiksberg Hospital , Copenhagen , Denmark . Primary Objective : To show small pTa bladder tumour safely remove diode laser outpatient department Secondary Objective : To evaluate patient experience laser treatment use QOL questionaires ( symptom evaluation ) Visual Analog Scale Score ( pain evaluation ) . Study Design : Open prospective study patient recurrent pTa low grade bladder tumour . All patient bladder tumour remove use diode laser . The treatment take place outpatient department ( OPD ) without pain treatment . Biopsy tumour obtain procedure . If biopsy show low grade non-invasive bladder tumour , flexible cystoscopy repeat one month later OPD . At procedure biopsy take laser treated area . If per-operative biopsy show high grade invasive tumour , patient refer re-resection operating theatre admittance urology ward . The pain valuate Visual Analogue Scale Score fill immediately procedure . Treatment induce symptom evaluate use QOL questionnaire patient fill one week laser treatment one week cystoscopies . Population : Patients histologically confirm pTa urothelial bladder tumour Number Subjects : Twenty patient Selection Subjects : Patients schedule trans urethral resection bladder tumour ( TUR-B ) less 1,5 cm operate theatre general anaesthesia without concomitant therapy anticoagulant Marevan , Marcoumar , new anticoagulant Pradaxa etc . informed consent include study . Equipment : Diode laser Storz , SPIES Biopsy forceps , Storz Key Dates : Overall duration study : 6 month include 1 month follow Efficacy Safety Variables Primary Endpoint : proportion patient bladder tumour completely remove one laser treatment . Secondary Endpoints : - Portion general urinary problem QOL laser treatment compare cystoscopy biopsy OPD - Pain laser treatment cystoscopy assess Visual Analog Scale ( VAS ) Score . Statistical Methods Planned Analysis : Non-parametric descriptive statistic perform Parameters case report form ( CRF ) : Bladder cancer diagnosis ( pTa low grade ) - Age - Sex - Mapping lesion normal , Clara Chrome , Spectra A B filter cystoscopy - Histology suspicious lesion - SEPARATE CYSTOSCOPYFORM laser TUR-B two follow cystoscopies - The duration laser treatment - Expected clearance laser TUR-B - The visibility laser TUR-B - Visual Analog Scale Score result ( measure pain laser treatment perform biopsy take OPD )</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>Recurrence pTa low grade urothelial bladder tumor Tumor &lt; 1.5 cm &lt; 6 tumor Patients porphyria Known hypersensitivity HexvixÂ® porphyrins Use anticoagulant Macroscopic hematuria Pregnant breast feed woman Expected poor compliance Patients &lt; 18 year Patients read understand Danish</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>